SIBN NASDAQ
SI-BONE, Inc.
1W: -2.7%
1M: -5.6%
3M: +2.3%
YTD: -8.6%
1Y: +26.7%
3Y: -13.7%
5Y: -22.8%
$18.08
-0.33 (-1.79%)
Weekly Expected Move ±3.2%
$17
$18
$18
$19
$19
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (37)
SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis
At a glance: stocks gapping up premarket
Bank of America Corp DE Raises Holdings in SiBone $SIBN
Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?
Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to Trade
Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?
Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance
Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' Now
Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should Know
How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27%
Why Si-Bone Stock Soared by Almost 20% on Tuesday
Why Harmonic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
SI-Bone (SIBN) Q1 2026 Earnings Transcript
Globus Medical (GMED) Tops Q1 Earnings and Revenue Estimates
Avanos Medical (AVNS) Lags Q1 Earnings Estimates
SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026
Integer (ITGR) Q1 Earnings Lag Estimates
SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026
SiBone $SIBN Stake Lowered by JPMorgan Chase & Co.
American Century Companies Inc. Acquires 521,683 Shares of SiBone $SIBN
SI-BONE outlines 14%-16% revenue growth for 2026 with new product launches and Smith & Nephew partnership
SI-BONE GAAP EPS of -$0.04 beats by $0.08, revenue of $56.3M in-line
Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates
SI-BONE, Inc. (SIBN) Q4 2025 Earnings Call Transcript
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance
Earnings Preview: Si-Bone (SIBN) Q4 Earnings Expected to Decline
SiBone (NASDAQ:SIBN) Receives Consensus Rating of “Moderate Buy” from Analysts
SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
Anshul Maheshwari Sells 18,542 Shares of SiBone (NASDAQ:SIBN) Stock
Michael Pisetsky Sells 19,600 Shares of SiBone (NASDAQ:SIBN) Stock
SiBone (NASDAQ:SIBN) Sets New 52-Week High Following Analyst Upgrade
Should You Buy Si-Bone (SIBN) After Golden Cross?
Intech Investment Management LLC Trims Stake in SiBone $SIBN
AXQ Capital LP Invests $290,000 in SiBone $SIBN